XML 33 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
IPO
ATM offering
Series A Convertible Preferred Stock
Series A Convertible Preferred Stock
Series A1 Convertible Preferred Shares
Subscriptions Receivables from Preferred Stockholders
Common Stock
Common Stock
IPO
Common Stock
ATM offering
Notes Receivable from Common Stockholders
Additional Paid-in Capital
Additional Paid-in Capital
IPO
Additional Paid-in Capital
ATM offering
Accumulated Deficit
Accumulated Other Comprehensive Income
Balance (in shares) at Dec. 31, 2017       0     26,249,993                
Balance at Dec. 31, 2017 $ (2)     $ 0   $ 0 $ 26     $ (5) $ 0     $ (23) $ 0
Issuance of Series A convertible preferred shares at $35.06 per share, net of issuance costs of $635 and $84 (in shares)       7,557,990 998,225                    
Issuance of Series A convertible preferred shares at $35.06 per share, net of issuance costs of $635 and $84       $ 264,365 $ 34,917                    
Issuance of Series A-1 convertible preferred shares at $35.06 per share in connection with asset acquisition (in shares)         3,187,772                    
Issuance of Series A-1 convertible preferred shares at $35.06 per share in connection with asset acquisition         $ 111,770                    
Proceeds received from common stockholders for issuance of founders' stock at inception 5                 5          
Subscriptions receivable from preferred stockholders (150,000)         (150,000)                  
Proceeds received from preferred stockholders 150,000         150,000                  
Issuance of common stock for exercise of stock options (in shares)             5,020,580                
Issuance of common stock for early exercise of stock options 5           $ 5                
Issuance of common stock, net of issuance costs (in shares)               20,700,000              
Issuance of common stock, net of issuance costs   $ 343,329           $ 21       $ 343,308      
Conversion of Series A convertible preferred stock (in shares)       (11,743,987)     61,655,922                
Conversion of Series A convertible preferred stock 411,052     $ (411,052)     $ 62       410,990        
Issuance of common stock upon conversion of convertible stock (in shares)             7,856,176                
Issuance of common stock upon conversion of convertible notes 141,410           $ 7       141,403        
Adjustment for fractional shares from forward stock split (2)                   (2)        
Stock-based compensation 18,566                   18,566        
Net loss (211,505)                         (211,505)  
Net unrealized loss on available-for-sale investments 306                           306
Balance (in shares) at Dec. 31, 2018       0     121,482,671                
Balance at Dec. 31, 2018 703,164     $ 0   $ 0 $ 121     $ 0 914,265     (211,528) 306
Issuance of common stock for exercise of stock options (in shares)             711,623                
Issuance of common stock for early exercise of stock options 2,959           $ 1       2,958        
Employee stock purchase plan (in shares)             107,982                
Employee stock purchase plan 1,783                   1,783        
Issuance of common stock, net of issuance costs (in shares)             1,965,082                
Issuance of common stock, net of issuance costs 54,219           $ 2       54,217        
Vesting of early exercised common stock 4,590                   4,590        
Stock-based compensation 46,063                   46,063        
Net loss (184,594)                         (184,594)  
Net unrealized loss on available-for-sale investments $ 839                           839
Balance (in shares) at Dec. 31, 2019 124,267,358           124,267,358                
Balance at Dec. 31, 2019 $ 629,023           $ 124       1,023,876     (396,122) 1,145
Issuance of common stock for exercise of stock options (in shares)             1,725,695                
Issuance of common stock for early exercise of stock options 8,815           $ 2       8,813        
Employee stock purchase plan (in shares)             175,142                
Employee stock purchase plan 2,843                   2,843        
Issuance of common stock, net of issuance costs (in shares)     848,663       13,457,447   848,663            
Issuance of common stock, net of issuance costs 595,730   $ 26,203       $ 13   $ 1   595,717   $ 26,202    
Vesting of early exercised common stock 2,840                   2,840        
Stock-based compensation 65,261                   65,261        
Net loss (250,221)                         (250,221)  
Net unrealized loss on available-for-sale investments $ (877)                           (877)
Balance (in shares) at Dec. 31, 2020 140,474,305           140,474,305                
Balance at Dec. 31, 2020 $ 1,079,617           $ 140       $ 1,725,552     $ (646,343) $ 268